| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | Chief Scientific Officer | Restricted Stock Units | 0 | $68,103 | $5.64 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $11.23 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 7 | $0 | 4 | Chief Scientific Officer | 28 Jul 2025, 17:15 |
| VERV | Verve Therapeutics, Inc. | 01 Apr 2025 | 4 | -$9,084 | 4 | Chief Scientific Officer | 03 Apr 2025, 17:00 |
| VERV | Verve Therapeutics, Inc. | 08 Jan 2025 | 2 | $0 | 4 | Chief Scientific Officer | 10 Jan 2025, 09:00 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Chief Scientific Officer | 25 Jun 2024, 17:05 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2024 | 0 | $0 | 3 | Chief Scientific Officer | 25 Jun 2024, 17:00 |